BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND PAX7, PAX7B, 5081, ENSG00000009709, P23759, HUP1
31 results:

  • 1. Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology Group.
    Martin-Giacalone BA; Li H; Scheurer ME; Casey DL; Dugan-Perez S; Marquez-Do DA; Muzny D; Gibbs RA; Barkauskas DA; Hall D; Stewart DR; Schiffman JD; McEvoy MT; Khan J; Malkin D; Linardic CM; Crompton BD; Shern JF; Skapek SX; Venkatramani R; Hawkins DS; Sabo A; Plon SE; Lupo PJ
    JAMA Netw Open; 2024 Mar; 7(3):e244170. PubMed ID: 38546643
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Inflammatory Rhabdomyoblastic Tumor: Clinicopathologic and Molecular Analysis of 13 Cases.
    Odate T; Satomi K; Kubo T; Matsushita Y; Ueno T; Kurose A; Shomori K; Nakai T; Watanabe R; Segawa K; Ohshika S; Miyake N; Kudo S; Shimoi T; Kobayashi E; Komiyama M; Yoshimoto S; Nakatani F; Kawai A; Yatabe Y; Kohsaka S; Ichimura K; Ichikawa H; Yoshida A
    Mod Pathol; 2024 Jan; 37(1):100359. PubMed ID: 37871654
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Significance of fusion status, Oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: Data of the European Soft Tissue Sarcoma Registry SoTiSaR.
    Heinz AT; Schönstein A; Ebinger M; Fuchs J; Timmermann B; Seitz G; Vokuhl C; Münter M; Pajtler KW; Stegmaier S; von Kalle T; Kratz CP; Ljungman G; Juntti H; Klingebiel T; Koscielniak E; Sparber-Sauer M;
    Pediatr Blood Cancer; 2024 Jan; 71(1):e30707. PubMed ID: 37814424
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series.
    McDonald J; Sayers J; Anker SD; Arends J; Balstad TR; Baracos V; Brown L; Bye A; Dajani O; Dolan R; Fallon MT; Fraser E; Griel C; Grzyb A; Hjermstad M; Jamal-Hanjani M; Jakobsen G; Kaasa S; McMillan D; Maddocks M; Philips I; Ottestad IO; Reid KF; Sousa MS; Simpson MR; Vagnildhaug OM; Skipworth RJE; Solheim TS; Laird BJA;
    J Cachexia Sarcopenia Muscle; 2023 Oct; 14(5):1932-1948. PubMed ID: 37671529
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Strontium-89 chloride delivery for painful bone metastases in patients with a history of prior irradiation.
    Saito AI; Inoue T; Kinoshita M; Kosaka T; Mitsuhashi T
    Ir J Med Sci; 2023 Apr; 192(2):569-574. PubMed ID: 35538276
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Pulmonary "Inflammatory Leiomyosarcomas" Are Indolent Tumors With Diploid Genomes and No Convincing Rhabdomyoblastic Differentiation.
    Kao YC; Kuo CT; Kuo PY; Huang HY; Lu TP; Hsieh TH; Fletcher CDM; Lee JC
    Am J Surg Pathol; 2022 Mar; 46(3):424-433. PubMed ID: 35175969
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Deficient muscle regeneration potential in sarcopenic COPD patients: Role of satellite cells.
    Sancho-Muñoz A; Guitart M; Rodríguez DA; Gea J; Martínez-Llorens J; Barreiro E
    J Cell Physiol; 2021 Apr; 236(4):3083-3098. PubMed ID: 32989805
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. An
    Bissonnette C; Shilo K; Liebner D; Rogers A; Pollock RE; Iwenofu OH
    Int J Surg Pathol; 2021 Feb; 29(1):109-116. PubMed ID: 32506986
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Inflammatory leiomyosarcoma shows frequent co-expression of smooth and skeletal muscle markers supporting a primitive myogenic phenotype: a report of 9 cases with a proposal for reclassification as low-grade inflammatory myogenic tumor.
    Michal M; Rubin BP; Kazakov DV; Michalová K; Šteiner P; Grossmann P; Hájková V; Martínek P; Švajdler M; Agaimy A; Hadravský L; Kalmykova AV; Konishi E; Heidenreich F; Michal M
    Virchows Arch; 2020 Aug; 477(2):219-230. PubMed ID: 32078043
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The TLR7/8/9 Antagonist IMO-8503 Inhibits cancer-Induced Cachexia.
    Calore F; Londhe P; Fadda P; Nigita G; Casadei L; Marceca GP; Fassan M; Lovat F; Gasparini P; Rizzotto L; Zanesi N; Jackson D; Mehta S; Nana-Sinkam P; Sampath D; Pollock RE; Guttridge DC; Croce CM
    Cancer Res; 2018 Dec; 78(23):6680-6690. PubMed ID: 30209066
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma.
    Yohe ME; Gryder BE; Shern JF; Song YK; Chou HC; Sindiri S; Mendoza A; Patidar R; Zhang X; Guha R; Butcher D; Isanogle KA; Robinson CM; Luo X; Chen JQ; Walton A; Awasthi P; Edmondson EF; Difilippantonio S; Wei JS; Zhao K; Ferrer M; Thomas CJ; Khan J
    Sci Transl Med; 2018 Jul; 10(448):. PubMed ID: 29973406
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Repeat biopsy of patients with acquired resistance to EGFR TKIs: implications of biopsy-related factors on T790M mutation detection.
    Kim H; Chae KJ; Yoon SH; Kim M; Keam B; Kim TM; Kim DW; Goo JM; Park CM
    Eur Radiol; 2018 Feb; 28(2):861-868. PubMed ID: 28786010
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial.
    Rosell R; Dafni U; Felip E; Curioni-Fontecedro A; Gautschi O; Peters S; Massutí B; Palmero R; Aix SP; Carcereny E; Früh M; Pless M; Popat S; Kotsakis A; Cuffe S; Bidoli P; Favaretto A; Froesch P; Reguart N; Puente J; Coate L; Barlesi F; Rauch D; Thomas M; Camps C; Gómez-Codina J; Majem M; Porta R; Shah R; Hanrahan E; Kammler R; Ruepp B; Rabaglio M; Kassapian M; Karachaliou N; Tam R; Shames DS; Molina-Vila MA; Stahel RA;
    Lancet Respir Med; 2017 May; 5(5):435-444. PubMed ID: 28408243
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Expression of CCAAT/Enhancer Binding Protein Beta in Muscle Satellite Cells Inhibits Myogenesis in cancer Cachexia.
    Marchildon F; Lamarche É; Lala-Tabbert N; St-Louis C; Wiper-Bergeron N
    PLoS One; 2015; 10(12):e0145583. PubMed ID: 26709824
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Myogenic transcription factors regulate pro-metastatic miR-182.
    Dodd RD; Sachdeva M; Mito JK; Eward WC; Brigman BE; Ma Y; Dodd L; Kim Y; Lev D; Kirsch DG
    Oncogene; 2016 Apr; 35(14):1868-75. PubMed ID: 26234681
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A study of alveolar rhabdomyosarcoma copy number alterations by single nucleotide polymorphism analysis.
    Lynn M; Shah N; Conroy J; Ennis S; Morris T; Betts D; O'Sullivan M
    Appl Immunohistochem Mol Morphol; 2014 Mar; 22(3):213-21. PubMed ID: 24614150
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Testicular fusocellular rhabdomyosarcoma as a metastasis of elbow sclerosing rhabdomyosarcoma: A clinicopathologic, immunohistochemical and molecular study of one case.
    Martorell M; Ortiz CM; Garcia JA
    Diagn Pathol; 2010 Aug; 5():52. PubMed ID: 20701800
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Induction chemotherapy followed by concurrent chemoradiation for patients with non-operable stage III non-small-cell lung cancer.
    Iranzo V; Bremnes RM; Almendros P; Gavilá J; Blasco A; Sirera R; Camps C
    Lung Cancer; 2009 Jan; 63(1):63-7. PubMed ID: 18550204
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Mortality in a cohort of sugar refinery workers in Arezzo Province, Italy].
    Battista G; Costantini AS; Gorini G; Orsi D; Paredes I; Miceli GB; De Vuono G; Peccetti V
    Med Lav; 2007; 98(4):289-95. PubMed ID: 17679341
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. MIRA-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells.
    Rauch T; Li H; Wu X; Pfeifer GP
    Cancer Res; 2006 Aug; 66(16):7939-47. PubMed ID: 16912168
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.